ArticleBMC pulmonary medicine2018

Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study.

Ye Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.